These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22812451)

  • 1. Principles and applications of selective biophysical methods for characterization and comparability assessment of a monoclonal antibody.
    Maity H; Lai Y; Srivastava A; Goldstein J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2078-101. PubMed ID: 22812451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Utility of Circular Dichroism and FTIR Spectroscopy in Monoclonal-Antibody Comparability Studies.
    Lin JC; Glover ZK; Sreedhara A
    J Pharm Sci; 2015 Dec; 104(12):4459-4466. PubMed ID: 26505267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
    Wen J; Batabyal D; Knutson N; Lord H; Wikström M
    J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glycosylation pattern on the molecular properties of monoclonal antibodies.
    Zheng K; Yarmarkovich M; Bantog C; Bayer R; Patapoff TW
    MAbs; 2014; 6(3):649-58. PubMed ID: 24662970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.
    Alsenaidy MA; Kim JH; Majumdar R; Weis DD; Joshi SB; Tolbert TJ; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Nov; 102(11):3942-56. PubMed ID: 24114789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.
    Ito T; Tsumoto K
    Protein Sci; 2013 Nov; 22(11):1542-51. PubMed ID: 23963869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
    Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
    Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
    Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
    Sahin E; Grillo AO; Perkins MD; Roberts CJ
    J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering.
    Ahrer K; Buchacher A; Iberer G; Jungbauer A
    J Biochem Biophys Methods; 2006 Mar; 66(1-3):73-86. PubMed ID: 16458360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
    Kiese S; Papppenberger A; Friess W; Mahler HC
    J Pharm Sci; 2008 Oct; 97(10):4347-66. PubMed ID: 18240293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature denaturation and aggregation of a multi-domain protein (IgG1) investigated with an array of complementary biophysical methods.
    Cerasoli E; Ravi J; Garfagnini T; Gnaniah S; le Pevelen D; Tranter GE
    Anal Bioanal Chem; 2014 Oct; 406(26):6577-86. PubMed ID: 24994667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical characterization of a model antibody drug conjugate.
    Arakawa T; Kurosawa Y; Storms M; Maruyama T; Okumura CJ; Maluf NK
    Drug Discov Ther; 2016; 10(4):211-7. PubMed ID: 27534450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
    Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
    J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.